Concord Biotech Q4 Results

  • BSE: 543960
  • NSE: CONCORDBIO
  • ISIN: INE338H01029
  • Sector: -
BSE
2,073.341.75 (2.06%)
Volume8.86 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
2,06949.70 (2.46%)
Volume1.66 L
Updated: Mon 25 Nov, 2024 | 15:30:03
Today: 2,002.20
2,099.95
52-Wk: 1,206.00
2,658.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Concord Biotech Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 23QoQ CompMar 23YoY Comp
    Total Revenue 318.97240.80-%853.17-%
    Selling/ General/ Admin Expenses Total 33.9630.67-%110.28-%
    Depreciation/ Amortization 13.7213.54-%54.03-%
    Other Operating Expenses Total 61.8857.11-%219.39-%
    Total Operating Expense 198.40148.40-%563.91-%
    Operating Income 120.5792.39-%289.26-%
    Net Income Before Taxes 128.72103.10-%322.01-%
    Net Income 95.0277.57-%240.09-%
    Diluted Normalized EPS 9.087.41-%22.95-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts